Liver Cancer Trial, Recruiting (NCT04499833)

Liver Cancer Trial, Recruiting NCT04499833 Sponsor: Centro Hospitalar de Lisboa Central Condition: Liver Cancer

Printed from Voxsanity (voxsanity.com.au) — NCT04499833 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Liver Cancer

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

You have been diagnosed with liver cancer (hepatocellular carcinoma) that is linked to liver scarring (cirrhosis)
You are between 18 and 70 years old
The total size of all your tumours combined is less than 500 cm³ (confirm with trial site)
You have fewer than 10 separate tumour spots in total
Your largest single tumour measures less than 10 cm across

Who may not be able to join:

You meet the so-called "Milan Criteria," which is a specific set of medical standards used to assess eligibility for liver transplants in cancer patients (confirm with trial site)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 12 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Hugo Pinto-Marques, MD PhD, Centro Hospitalar Universitário de Lisboa Central

Phone: +351917302214

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT04499833

Sponsor: Centro Hospitalar de Lisboa Central

Phase: Not Applicable

Status: Recruiting

Condition: Liver Cancer

Trial contact: +351917302214

More information: https://clinicaltrials.gov/study/NCT04499833

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

You have been diagnosed with liver cancer (hepatocellular carcinoma) that is linked to liver scarring (cirrhosis)
You are between 18 and 70 years old
The total size of all your tumours combined is less than 500 cm³ (confirm with trial site)
You have fewer than 10 separate tumour spots in total
Your largest single tumour measures less than 10 cm across

Who may not be able to join:

You meet the so-called "Milan Criteria," which is a specific set of medical standards used to assess eligibility for liver transplants in cancer patients (confirm with trial site)

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 12 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Centro Hospitalar de Lisboa Central

Registry

ClinicalTrials.gov

Start date

25 March 2021

Est. completion

30 October 2028

Where this trial is recruiting

🇵🇹 Portugal

Primary endpoints

death; hepatocellular carcinoma recurrence

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 12 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov